International Journal of Endocrinology

New Diagnostic and Therapeutic Tools for Thyroid Cancer


Publishing date
29 Mar 2013
Status
Published
Submission deadline
09 Nov 2012

1Center for Medical Research, Medical University of Graz, 8010 Graz, Austria

2The Medical Center of Postgraduate Education, 01-813 Warsaw, Poland

3Endocrine Unit, Evgenidion Hospital, University of Athens Medical School, 11528 Athens, Greece

4Medical Clinic, Department of Medicine IV (Diabetology, Endocrinology, Angiology, Nephrology, and Clinical Chemistry), University of Tuebingen, 72076 Tuebingen, Germany


New Diagnostic and Therapeutic Tools for Thyroid Cancer

Description

The incidence of thyroid cancer worldwide is increasing. It is the commonest endocrine malignancy but represents only 1% of all cancers. Whereas the prognosis of differentiated thyroid cancer is good, the survival time of anaplastic thyroid cancer and of medullary thyroid cancer is still very short. More precise diagnosis with better stratification of patients and identification of risk patients as well as personalized treatment may improve the prognosis of thyroid cancer. Treatment of thyroid cancer is multidisciplinary and involves endocrinologists, nuclear medicine specialists, and surgeons, and the special issue aims to collect contributions from these different fields.

We invite investigators to contribute original articles and review articles addressing advances in diagnosis and therapy of all types of differentiated thyroid cancer, anaplastic thyroid cancer, and medullary thyroid cancer. The submission of manuscript on innovative approaches (e.g., diagnostic and therapeutic nanoparticles, gene therapy, new targets for differentiation therapy) is highly encouraged. Potential topics include, but are not limited to:

  • Risk factors for thyroid cancer
  • Role of immune cells (e.g., regulatory T cells)
  • New in vitro and animal models for thyroid cancer
  • Imaging options in thyroid cancer
  • Molecular diagnosis of thyroid cancer
  • Predictive (bio)markers for thyroid cancer
  • Histopathological tools for improved diagnosis
  • Targeted therapies (e.g., tyrosine kinase inhibitors, antiangiogenesis drugs), immunotherapy, peptide receptor radionuclide therapy, and innovative formulations for thyroid cancer
  • Improved protocols in surgical resection, radiation, and radioiodine treatment
  • Clinical studies of rare thyroid cancer manifestations

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ije/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 312378
  • - Editorial

New Diagnostic and Therapeutic Tools for Thyroid Cancer

Eleonore Fröhlich | Richard Wahl | ... | Leonidas Duntas
  • Special Issue
  • - Volume 2013
  • - Article ID 856189
  • - Review Article

The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview

Giorgio Treglia | Salvatore Annunziata | ... | Luca Giovanella
  • Special Issue
  • - Volume 2013
  • - Article ID 210639
  • - Research Article

Estimation of True Serum Thyroglobulin Concentration Using Simultaneous Measurement of Serum Antithyroglobulin Antibody

Byeong-Cheol Ahn | Won Kee Lee | ... | Jaetae Lee
  • Special Issue
  • - Volume 2013
  • - Article ID 384508
  • - Research Article

Glucagon-Like Peptide-1 Receptor Imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report

D. Pach | A. Sowa-Staszczak | ... | A. Hubalewska-Dydejczyk
  • Special Issue
  • - Volume 2013
  • - Article ID 803171
  • - Review Article

Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma

Serena Giunti | Alessandro Antonelli | ... | Libero Santarpia
  • Special Issue
  • - Volume 2013
  • - Article ID 317487
  • - Review Article

Comprehensive Literature Review: Recent Advances in Diagnosing and Managing Patients with Poorly Differentiated Thyroid Carcinoma

Jack Hannallah | Jessica Rose | Marlon A. Guerrero
  • Special Issue
  • - Volume 2012
  • - Article ID 379097
  • - Clinical Study

Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV

Sheng-Hwu Hsieh | Szu-Tah Chen | ... | Jen-Der Lin
International Journal of Endocrinology
 Journal metrics
Acceptance rate35%
Submission to final decision48 days
Acceptance to publication46 days
CiteScore3.500
Impact Factor2.299
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.